Klinische und immunhistochemische Aspekte der Diagnostik von anaplastischen großzelligen CD30-positiven Lymphomen

Zusammenfassung

Nach einem kurzen Überblick über die Literatur werden klinische Fälle zur Diagnostik von anaplastischen großzelligen CD30-positiven Lymphomen beschrieben.

Abstract

After a brief review of the literature, cases with their clinical diagnostics in anaplastic large cell CD30 + lymphomas are described.

• Literatur

• 1 Lezvinskaya EM, Vavilov AM. Lymphoproliferative Tumoren der Haut: Leitfaden für Ärzte. Moskau: praktische Medizin; 2010: 336
• 2 Krivolapov JA, Leenman EE. Morphologische Diagnostik des Lymphoms. St. Petersburg: IPK Kosta; 2006: 208
• 3 Shi XL, Tang XW, Wu DP. Reseach progresses in the pathogenesis of anaplastic large cell lymphoma. Chinese Journal of Cancer 2011; 30: 392-399
• 4 Pileri SA, Agostinelli C, Bacci F et al. Pathobiology of ALK-negative anaplastic large cell Lymphoma. Pediatric reports 2011; 3: 8-10
• 5 Boulland ML, Wechsler J, Bagot M et al. Primary CD30 positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins. Histopathology 2000; 36: 136-144
• 6 Savage KJ, Harris NL, Vose JM et al. ALK anaplastic Large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008; 111: 496-504
• 7 Kadin ME, Carpenter C. Systemic and primary cutaneous anaplastic large cell lymphomas. Semin Hematol 2003; 40: 244-256